Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide

John Louis Colombo, S. M. Stolz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This report describes a five-year-old boy with severe pulmonary hemorrhage caused by primary pulmonary hemosiderosis with cow's milk sensitivity. After failing to respond to corticosteroids and azathioprine, he dramatically improved after being given cyclophosphamide. He worsened after discontinuation of cyclophosphamide on two occasions and improved significantly with its reinstitution. Cyclophosphamide was continued for 14 months without further bleeding or adverse effects. The patient has remained in remission for nearly five years. Cyclophosphamide may be a life saving alternative therapy for refractory pulmonary hemorrhage with pulmonary hemosiderosis.

Original languageEnglish (US)
Pages (from-to)959-960
Number of pages2
JournalChest
Volume102
Issue number3
DOIs
StatePublished - Jan 1 1992

Fingerprint

Cyclophosphamide
Hemorrhage
Lung
Azathioprine
Therapeutics
Complementary Therapies
Adrenal Cortex Hormones
Milk
Idiopathic pulmonary hemosiderosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide. / Colombo, John Louis; Stolz, S. M.

In: Chest, Vol. 102, No. 3, 01.01.1992, p. 959-960.

Research output: Contribution to journalArticle

@article{5803ba7fe5654a89b2cb6e9148f65f99,
title = "Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide",
abstract = "This report describes a five-year-old boy with severe pulmonary hemorrhage caused by primary pulmonary hemosiderosis with cow's milk sensitivity. After failing to respond to corticosteroids and azathioprine, he dramatically improved after being given cyclophosphamide. He worsened after discontinuation of cyclophosphamide on two occasions and improved significantly with its reinstitution. Cyclophosphamide was continued for 14 months without further bleeding or adverse effects. The patient has remained in remission for nearly five years. Cyclophosphamide may be a life saving alternative therapy for refractory pulmonary hemorrhage with pulmonary hemosiderosis.",
author = "Colombo, {John Louis} and Stolz, {S. M.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1378/chest.102.3.959",
language = "English (US)",
volume = "102",
pages = "959--960",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "3",

}

TY - JOUR

T1 - Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide

AU - Colombo, John Louis

AU - Stolz, S. M.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - This report describes a five-year-old boy with severe pulmonary hemorrhage caused by primary pulmonary hemosiderosis with cow's milk sensitivity. After failing to respond to corticosteroids and azathioprine, he dramatically improved after being given cyclophosphamide. He worsened after discontinuation of cyclophosphamide on two occasions and improved significantly with its reinstitution. Cyclophosphamide was continued for 14 months without further bleeding or adverse effects. The patient has remained in remission for nearly five years. Cyclophosphamide may be a life saving alternative therapy for refractory pulmonary hemorrhage with pulmonary hemosiderosis.

AB - This report describes a five-year-old boy with severe pulmonary hemorrhage caused by primary pulmonary hemosiderosis with cow's milk sensitivity. After failing to respond to corticosteroids and azathioprine, he dramatically improved after being given cyclophosphamide. He worsened after discontinuation of cyclophosphamide on two occasions and improved significantly with its reinstitution. Cyclophosphamide was continued for 14 months without further bleeding or adverse effects. The patient has remained in remission for nearly five years. Cyclophosphamide may be a life saving alternative therapy for refractory pulmonary hemorrhage with pulmonary hemosiderosis.

UR - http://www.scopus.com/inward/record.url?scp=0026784582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026784582&partnerID=8YFLogxK

U2 - 10.1378/chest.102.3.959

DO - 10.1378/chest.102.3.959

M3 - Article

C2 - 1516434

AN - SCOPUS:0026784582

VL - 102

SP - 959

EP - 960

JO - Chest

JF - Chest

SN - 0012-3692

IS - 3

ER -